HomeAuthorsPosts by Sam Atkinson

Sam Atkinson

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge in profit for the third quarter ended May 31, 2026. This performance marks a decisive shift from a period of recovery toward a new phase of resilient growth in the...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the country grapples with a growing burden of non-communicable diseases (NCDs), particularly diabetes and chronic kidney disease. Recent estimates show that one-in-six Malaysians has diabetes, while one-in-seven is at risk of chronic...
spot_img

Keep exploring

SGX-LISTED COMPANIES

Is Camsing Healthcare In Survival Mode? The Truth Behind Their Q3 FY2026

On the Brink of Collapse: 3 Surprising Truths Buried in Camsing Healthcare's Latest Report 1....
SGX-LISTED COMPANIES

Restructuring Is Reshaping ecoWise’s Future After Q2 FY2026

ecoWise Sales Are Up 12%. So Why Is It Still Losing Money? Four Key...
SGX-LISTED COMPANIES

How Vibrant Group Grew Profits Despite Falling Revenue In 1H FY2026

The Vibrant Group Paradox: A Masterclass in Growing Profits by 35% While Sales Declined Introduction: What...
SGX-LISTED COMPANIES

This Massive 1H FY2026 Revenue Surge Is Changing Everything For XMH Holdings

Beyond the Boom: 5 Unexpected Takeaways from XMH Holdings' Financials Introduction: At first glance, the latest...
SGX-LISTED COMPANIES

How Stamford Tyres Found Extra Cash Amid Market Chaos In 1H FY26

5 Surprising Truths We Found Buried in a Tyre Firms Financial Report Introduction: Financial documents can...
SGX-LISTED COMPANIES

How Del Monte Delivered A 700% Profit Surge In Q2 FY2026

How Del Monte Pacific Engineered a 737% Profit Surge After Axing Its U.S. Business Sometimes,...
SGX-LISTED COMPANIES

Nam Lee Pressed Metal Profits Surged 102.7% In FY2025

Smarter Sales, Not Just More Sales: Deconstructing Nam Lee's 102.7% Profit Surge Introduction: Nam Lee's latest...
SGX-LISTED COMPANIES

Marco Polo Marine Profits Skyrocketed By 170% In FY2025

Marco Polo Marine’s Profit Skyrocketed 170%. The Real Story is Even More Surprising Marco Polo...
SGX-LISTED COMPANIES

LHN’s FY2025 Profit Paradox

LHN's Net Profit Fell 55%. Here Are 5 Reasons It Was Actually a Landmark...
SGX-LISTED COMPANIES

Acrometa Group FY2025 Profit Vanishes After One-Off Gain

Revenue Down, Cash Up? 4 Shocking Truths in Acrometa's Latest Financials Beneath the surface of...
SGX-LISTED COMPANIES

How Goodland Group Flipped Loss To Profit In FY2025

How a $4.6M Revenue Drop Led to a Stunning $3.9M Profit Turnaround Introduction: It’s a common...
SGX-LISTED COMPANIES

Booming Sales, Vanishing Profits At PNE Industries FY2025

PNE Industries: Sales Soared 17%, But Profits Crashed 60%. Here Are 5 Surprising Takeaways Introduction:...
Load more

Latest articles

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
Pharmaceutical

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...
Pharmaceutical

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...